Skip to main content

Table 2 Association statistics between genetic polymorphisms located within the HLA-DRB1 gene and disease mortality

From: HLA-DRB1 haplotypes predict cardiovascular mortality in inflammatory polyarthritis independent of CRP and anti-CCP status

Amino acid/haplotype/group

Inflammatory polyarthritis (IP)

Rheumatoid arthritis (RA)

All-cause mortality

Cardiovascular mortality

All-cause mortality

Cardiovascular mortality

Hazard ratio (95% CI)

p value

n

Hazard ratio (95% CI)

p value

n

Hazard ratio (95% CI)

p value

n

Hazard ratio (95% CI)

p value

n

Valine 11

1.16 (1.03, 1.30)

0.015

643 (2514)

1.10 (0.93, 1.30)

0.255

343 (2514)

1.10 (0.95, 1.28)

0.217

367 (1160)

0.96 (0.77, 1.19)

0.699

189 (1160)

Serine 11

0.83 (0.75, 0.94)

0.003

643 (2514)

0.82 (0.70, 0.96)

0.016

343 (2514)

0.83 (0.71, 0.97)

0.022

367 (1160)

0.86 (0.69, 1.07)

0.177

189 (1160)

Difference

1.26 (1.09, 1.45)

0.001

 

1.23 (1.01, 1.49)

0.038

 

1.22 (1.01, 1.47)

0.035

 

1.08 (0.83, 1.41)

0.559

 

VKA haplotype

1.15 (0.99, 1.34)

0.073

579 (2328)

1.16 (0.94, 1.43)

0.158

310 (2328)

1.14 (0.94, 1.38)

0.190

333 (1078)

1.05 (0.79, 1.40)

0.715

167 (1078)

SEA haplotype

0.76 (0.59, 0.96)

0.024

579 (2328)

0.67 (0.47, 0.94)

0.023

310 (2328)

0.63 (0.44, 0.89)

0.009

333 (1078)

0.49 (0.28, 0.85)

0.011

167 (1078)

Difference

1.46 (1.11, 1.93)

0.007

 

1.67 (1.13, 2.48)

0.010

 

1.75 (1.19, 2.58)

0.005

 

2.09 (1.14, 3.84)

0.018

 

Group 1

1.11 (0.98, 1.26)

0.101

579 (2328)

1.10 (0.93, 1.31)

0.266

319 (2328)

1.04 (0.89, 1.23)

0.622

333 (1078)

0.96 (0.76, 1.21)

0.720

167 (1078)

Group 4

0.78 (0.67, 0.90)

0.001

579 (2328)

0.73 (0.60, 0.89)

0.002

319 (2328)

0.76 (0.63, 0.93)

0.007

333 (1078)

0.72 (0.55, 0.96)

0.025

167 (1078)

Difference

1.31 (1.11, 1.54)

0.001

 

1.37 (1.09, 1.72)

0.007

 

1.27 (1.02, 1.58)

0.034

 

1.25 (0.91, 1.73)

0.168

 
  1. “Group 1” and “Group 4” refer to groups of haplotypes as previously defined in a previous publication [9]. Valine at position 11, the VKA haplotype and “group 1” haplotypes have previously been shown to be associated with the highest risk of susceptibility to RA [5]. Conversely, serine at position 11, the SEA haplotype and “group 4” haplotypes have been shown to be associated with the lowest risk [9]. Results are displayed as hazard ratios (HR) with 95% confidence intervals. The total number (n) of deaths is also displayed alongside the total number (n) of patients included in each analysis (in brackets). All models have been adjusted for cardiovascular risk factors namely; gender, hypertension and obesity. HR was not adjusted for other amino acids/haplotypes/groups. “Difference”: the difference in HR was calculated by the linear combination of the two HR obtained from a bivariate analysis (both amino acids/haplotypes/groups included in the same model). This represents the risk of death for the carriage of the highest risk susceptibility amino acid/haplotype/group, compared to the lowest risk amino acid/haplotype/group